"Fenway Health's Ansin Building at 1340 Boylston St. is your one-stop shop for full-service medical, behavioral health, dental and eye care. We also have a full-service pharmacy and offer a variety of services from HIV and STD testing to complementary therapies, LGBT parenting services, a Violence Recovery Program and women’s health and transgender health services. For your convenience, we offer extended hours in the evenings and on Saturdays. For more information: Appointments - 617.267.0900 Pharmacy Refill Line - 617.927.6330 Medical Referral Fax - 617.267.0900"

During the past decade, Fenway Community Health conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 21 clinical trials were completed, i.e. on average, 65.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 14 clinical trials were completed. i.e. 93.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fenway Community Health" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 24 trials, followed by "Fenway Community Health" with 10 trials sponsored, "Massachusetts General Hospital" with 5 trials sponsored, "Brigham and Women's Hospital" with 4 trials sponsored and "AIDS Malignancy Consortium" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fenway Community Health" #1 collaborator was "National Institute of Mental Health (NIMH)" with 9 trials as a collaborator, "Gilead Sciences" with 6 trials as a collaborator, "Fenway Community Health" with 5 trials as a collaborator, "The Fenway Institute" with 5 trials as a collaborator and "Brown University" with 4 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Fenway Community Health" are "HIV Infections" (40 trials), "HIV" (8 trials), "HIV Infection" (7 trials), "Adherence, Medication" (4 trials) and "HIV/AIDS" (4 trials). Many other conditions were trialed in "Fenway Community Health" in a lesser frequency.

Most popular intervention types in "Fenway Community Health" are "Drug" (24 trials), "Biological" (22 trials), "Behavioral" (20 trials), "Other" (9 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Efavirenz" (3 trials), "Lamivudine" (3 trials), "Ad26.Mos4.HIV" (2 trials) and "Behavioral intervention" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fenway Community Health" are 48 trials for "All" genders, 24 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Fenway Community Health". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Fenway Community Health, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fenway Community Health, 18 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 16 trials that are defined as “Not Applicable".